REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,265,487 | -27.6% | 371,882 | +59.7% | 0.00% | -100.0% |
| Q2 2023 | $5,892,143 | -11.1% | 232,799 | +13.1% | 0.00% | 0.0% |
| Q1 2023 | $6,627,208 | -6.3% | 205,750 | -46.3% | 0.00% | -50.0% |
| Q4 2022 | $7,070,623 | -74.6% | 383,024 | -62.9% | 0.00% | -71.4% |
| Q3 2022 | $27,842,000 | +124.6% | 1,031,169 | +15.0% | 0.01% | +133.3% |
| Q2 2022 | $12,395,000 | -25.2% | 896,984 | +5.5% | 0.00% | 0.0% |
| Q1 2022 | $16,574,000 | +525.4% | 849,893 | +423.5% | 0.00% | – |
| Q4 2021 | $2,650,000 | -74.7% | 162,358 | -56.8% | 0.00% | -100.0% |
| Q3 2021 | $10,466,000 | -21.6% | 375,672 | -16.6% | 0.00% | -33.3% |
| Q2 2021 | $13,356,000 | +54.8% | 450,620 | +46.0% | 0.00% | +50.0% |
| Q1 2021 | $8,626,000 | -25.5% | 308,600 | -24.5% | 0.00% | -33.3% |
| Q4 2020 | $11,585,000 | -26.9% | 408,783 | -35.1% | 0.00% | -25.0% |
| Q3 2020 | $15,843,000 | +932.1% | 630,182 | +902.7% | 0.00% | – |
| Q2 2020 | $1,535,000 | +46.2% | 62,847 | -11.3% | 0.00% | – |
| Q1 2020 | $1,050,000 | +33.4% | 70,879 | +46.0% | 0.00% | – |
| Q4 2019 | $787,000 | -65.1% | 48,536 | -72.0% | 0.00% | -100.0% |
| Q3 2019 | $2,255,000 | +13.3% | 173,452 | +13.1% | 0.00% | 0.0% |
| Q2 2019 | $1,990,000 | -45.7% | 153,423 | -34.0% | 0.00% | -50.0% |
| Q1 2019 | $3,664,000 | +703.5% | 232,551 | +925.0% | 0.00% | – |
| Q4 2018 | $456,000 | -85.7% | 22,689 | -82.3% | 0.00% | -100.0% |
| Q3 2018 | $3,186,000 | -35.9% | 128,169 | -29.3% | 0.00% | -50.0% |
| Q2 2018 | $4,974,000 | +57.7% | 181,197 | +76.9% | 0.00% | +100.0% |
| Q1 2018 | $3,154,000 | +28.7% | 102,411 | +49.4% | 0.00% | 0.0% |
| Q4 2017 | $2,451,000 | +453.3% | 68,554 | +325.8% | 0.00% | – |
| Q3 2017 | $443,000 | +108.0% | 16,100 | +32.2% | 0.00% | – |
| Q1 2016 | $213,000 | -71.9% | 12,178 | -48.5% | 0.00% | -100.0% |
| Q2 2015 | $757,000 | -10.5% | 23,656 | -52.7% | 0.00% | 0.0% |
| Q4 2014 | $846,000 | +58.7% | 49,974 | +81.4% | 0.00% | 0.0% |
| Q3 2014 | $533,000 | -87.5% | 27,554 | -78.0% | 0.00% | -80.0% |
| Q2 2014 | $4,260,000 | +67.8% | 125,289 | +55.4% | 0.01% | +66.7% |
| Q1 2014 | $2,539,000 | – | 80,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |